7¿ù 2ÀÏ(±Ý) |
|
|
|
µî·ÏÈ®ÀÎ |
³»ºÐºñÇÐȸ |
|
Àλç |
ȸÀå ±è¿ë±â |
|
½Å°æ³»ºÐºñ ¹× ³úÇϼöü |
ÁÂÀå - ±è¼º¿î |
9:00~9:25 |
³»ºÐºñ ¿µ»ó: CT & MRI of Hypothalamus and Pituitary Gland and it¡¯s Disorders |
¿¬¼¼ÀÇ´ë ¿µ»óÀÇÇаú À̽±¸ |
9:25~9:50 |
Pre-Op Evaluation and Post-Op Management of Sellar Masses |
ÀÎÁ¦ÀÇ´ë ¹ÚÁ¤Çö |
9:50~10:15 |
Medical Treatment of Prolactinoma and Acromegaly |
ÇѾçÀÇ´ë ±èµ¿¼± |
10:15~10:40 |
Disorders of Posterior Pituitary Gland |
°üµ¿ÀÇ´ë ±èÇüÁø |
10:40~11:00 |
ÁúÀÇÀÀ´ä ¹× ÈÞ½Ä |
|
°©»ó¼± |
ÁÂÀå - ±Ã¼º¼ö |
11:00~11:25 |
Antithyroidal Drugs, Radioactive Iodine and Thyroidectomy |
¼¿ïÀÇ´ë ¹Ú¿µÁÖ |
11:25~11:50 |
Thyroid Cytology Review |
¿ï»êÀÇ´ë º´¸®°ú °ø°æ¿± |
11:50~12:15 |
Pregnancy and Thyroid Diseases |
°üµ¿ÀÇ´ë ÀÓâÈÆ |
12:15~12:40 |
Hashimoto¡¯s thyroiditis |
¼º±Õ°üÀÇ´ë Á¤ÀçÈÆ |
12:40~1:50 |
Áᫎ |
|
´ç´¢º´, ÁöÁú´ë»ç ¹× »ý½Ä |
ÁÂÀå - ¹Ú¼º¿ì |
1:50~2:15 |
Genetic Factors in the Development of Type 2 Diabetes |
¼¿ïÀÇ´ë ¹Ú°æ¼ö |
2:15~2:40 |
Autoimmunity in Diabetes |
ÇѾçÀÇ´ë ¹Ú¿ë¼ö |
2:40~3:05 |
Primary Disorders of Hyperlipidemias |
¿ø±¤ÀÇ´ë ¹Úº´Çö |
3:05~3:30 |
MEN (Multiple Endocrine Neoplasia) |
ÇѸ²ÀÇ´ë ±èö½Ä |
3:30~3:50 |
ÁúÀÇ ÀÀ´ä ¹× ÈÞ½Ä |
|
°ñ´ë»ç ¹× Ư° |
ÁÂÀå - Àӽ±æ |
3:50~4:15 |
Disorders of Phosphorus Homeostasis |
°¡Å縯ÀÇ´ë ¹é±âÇö |
4:15~4:40 |
Assessment of Bone Strength |
¾ÆÁÖÀÇ´ë Á¤À±¼® |
4:40~5:05 |
Estrogen and Bone Health |
¼øõÇâÀÇ´ë º¯µ¿¿ø |
5:05~5:30 |
Bisphosphonate Treatment |
Àü³²ÀÇ´ë Á¤µ¿Áø |
|
Ư° |
¿¬ÀÚ¼Ò°³: Àӽ±æ |
5:30~6:10 |
´ëÇÑ ³»ºÐºñÇÐȸÀÇ ¹ßÀÚÃë (⸳°ú ¹ßÀü) |
CHAÀÇ°úÇдëÇб³ ÃÖ¿µ±æ |
6:10~6:30 |
ÈÞ½Ä ¹× Á¤¸® |
6:30~7:10 |
¼®½Ä |
7:10~9:00 |
Ä£±³ÀÇ ½Ã°£ |
Ãѹ«ÀÌ»ç |
|
7¿ù 3ÀÏ(Åä) |
|
|
|
Molecular Endocrinology Review |
ÁÂÀå - ÀÌÀºÁ÷ |
8:00~8:30 |
Thyroid Hormone Action |
Ãæ³²ÀÇ´ë ¼Û¹ÎÈ£ |
8:30~9:00 |
Adipocyte Biology: Adipogenesis and Adipocytokines |
¿¬¼¼ÀÇ´ë Â÷ºÀ¼ö |
9:00~9:30 |
Beta Cell Biology: Development and Maintenance of Beta Cell Mass |
°¡Å縯ÀÇ´ë À±°ÇÈ£ |
9:30~10:00 |
Bone Biology: Osteoblast, Osteoclast, and Osteocyte Interaction |
°æÈñÀÇ´ë Á¤È£¿¬ |
10:00~10:20 |
ÁúÀÇÀÀ´ä ¹× ÈÞ½Ä |
|
|
Vascular Endocrinology |
ÁÂÀå - ±è¼º¿¬
|
10:20~10:50 |
Renin-Angiotensin system & Essential and Secondary Hypertension |
¼º±Õ°üÀÇ´ë ¹Ú¼¼Àº |
10:50~11:20 |
Endothelial Dysfunction and Diabetic Complications |
°æºÏÀÇ´ë ±èÁ¤±¹ |
11:20~11:50 |
Molecular biology of Atherosclerosis |
°æÈñÀÇ´ë Á¤Àΰæ |
11:50~1:00 |
Áᫎ |
|
ºÎ½Å ¹× ±âŸ Áúȯ |
ÁÂÀå - ±è¿ë±â
|
1:00~1:25 |
Differential Diagnosis of Cushing Syndrome |
°æÈñÀÇ´ë ¿À½ÂÁØ |
1:25~1:50 |
Diagnostic and Therapeutic Approaches to Pheochromocytoma and Paraganglioma |
°í·ÁÀÇ´ë ±è½Å°ï |
1:50~2:15 |
Primary Mineralcorticoid-Excess States |
¼¿ïÀÇ´ë ±è»ó¿Ï |
2:15~2:40 |
Gynecomastia and Hirsutism |
ÀÌÈÀÇ´ë ¼º¿¬¾Æ |
2:40~3:00 |
Á¾ÇÕÁúÀÇ |
3:00~3:30 |
Æóȸ»ç ¹× ¼ö·áÁõ ÁõÁ¤ |
ÀÌ»çÀå Àӽ±æ |